Your browser doesn't support javascript.
loading
Understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study.
Haebich, Kristina M; Pride, Natalie A; Walsh, Karin S; Chisholm, Anita; Rouel, Melissa; Maier, Alice; Anderson, Vicki; Barton, Belinda; Silk, Tim; Korgaonkar, Mayuresh; Seal, Marc; Lami, Francesca; Lorenzo, Jennifer; Williams, Katrina; Dabscheck, Gabriel; Rae, Caroline D; Kean, Michael; North, Kathryn N; Payne, Jonathan M.
Afiliación
  • Haebich KM; Brain and Mind, Murdoch Children's Research Institute, Parkville, VIC, Australia.
  • Pride NA; Department of Paediatrics, Faculty of Medicine, Dentistry and Health Science, University of Melbourne, Parkville, VIC, Australia.
  • Walsh KS; Kids Neuroscience Centre, The Children's Hospital at Westmead, Westmead, NSW, Australia.
  • Chisholm A; Discipline of Child and Adolescent Health, University of Sydney Medical School, Westmead, NSW, Australia.
  • Rouel M; Center for Neuroscience and Behavioral Medicine, Children's National Health System, Washington, DC, United States.
  • Maier A; Departments of Pediatrics and Psychiatry, The George Washington University School of Medicine, Washington, DC, United States.
  • Anderson V; Brain and Mind, Murdoch Children's Research Institute, Parkville, VIC, Australia.
  • Barton B; Department of Paediatrics, Faculty of Medicine, Dentistry and Health Science, University of Melbourne, Parkville, VIC, Australia.
  • Silk T; Kids Neuroscience Centre, The Children's Hospital at Westmead, Westmead, NSW, Australia.
  • Korgaonkar M; Brain and Mind, Murdoch Children's Research Institute, Parkville, VIC, Australia.
  • Seal M; Brain and Mind, Murdoch Children's Research Institute, Parkville, VIC, Australia.
  • Lami F; Department of Paediatrics, Faculty of Medicine, Dentistry and Health Science, University of Melbourne, Parkville, VIC, Australia.
  • Lorenzo J; Kids Neuroscience Centre, The Children's Hospital at Westmead, Westmead, NSW, Australia.
  • Williams K; Discipline of Child and Adolescent Health, University of Sydney Medical School, Westmead, NSW, Australia.
  • Dabscheck G; Children's Hospital Education Research Institute, The Children's Hospital at Westmead, Westmead, NSW, Australia.
  • Rae CD; School of Psychology, Deakin University, Burwood, VIC, Australia.
  • Kean M; Brain Dynamics Centre, Westmead Institute for Medical Research, University of Sydney, Westmead, NSW, Australia.
  • North KN; Developmental Imaging, Murdoch Children's Research Institute, Parkville, VIC, Australia.
  • Payne JM; Brain and Mind, Murdoch Children's Research Institute, Parkville, VIC, Australia.
BMJ Open ; 9(9): e030601, 2019 09 26.
Article en En | MEDLINE | ID: mdl-31558455
INTRODUCTION: Children with the single-gene disorder neurofibromatosis type 1 (NF1) appear to be at an increased risk for autism spectrum disorder (ASD) and exhibit a unique social-cognitive phenotype compared with children with idiopathic ASD. A complete framework is required to better understand autism in NF1, from neurobiological levels through to behavioural and functional outcomes. The primary aims of this study are to establish the frequency of ASD in children with NF1, examine the social cognitive phenotype, investigate the neuropsychological processes contributing to ASD symptoms and poor social functioning in children with NF1, and to investigate novel structural and functional neurobiological markers of ASD and social dysfunction in NF1. The secondary aim of this study is to compare the neuropsychological and neurobiological features of ASD in children with NF1 to a matched group of patients with idiopathic ASD. METHODS AND ANALYSIS: This is an international, multisite, prospective, cross-sectional cohort study of children with NF1, idiopathic ASD and typically developing (TD) controls. Participants will be 200 children with NF1 (3-15 years of age), 70 TD participants (3-15 years) and 35 children with idiopathic ASD (7-15 years). Idiopathic ASD and NF1 cases will be matched on age, sex and intelligence. All participants will complete cognitive testing and parents will rate their child's behaviour on standardised questionnaires. Neuroimaging will be completed by a subset of participants aged 7 years and older. Children with NF1 that screen at risk for ASD on the parent-rated Social Responsiveness Scale 2nd Edition will be invited back to complete the Autism Diagnostic Observation Scale 2nd Edition and Autism Diagnostic Interview-Revised to determine whether they fulfil ASD diagnostic criteria. ETHICS AND DISSEMINATION: This study has hospital ethics approval and the results will be disseminated through peer-reviewed publications and international conferences.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Fenotipo / Conducta Social / Conducta Infantil / Neurofibromatosis 1 / Cognición / Trastorno del Espectro Autista Tipo de estudio: Observational_studies / Prevalence_studies Límite: Adolescent / Child / Child, preschool / Female / Humans / Male Idioma: En Revista: BMJ Open Año: 2019 Tipo del documento: Article País de afiliación: Australia

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Fenotipo / Conducta Social / Conducta Infantil / Neurofibromatosis 1 / Cognición / Trastorno del Espectro Autista Tipo de estudio: Observational_studies / Prevalence_studies Límite: Adolescent / Child / Child, preschool / Female / Humans / Male Idioma: En Revista: BMJ Open Año: 2019 Tipo del documento: Article País de afiliación: Australia